These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34220485)

  • 1. Niacin Enhancement for Parkinson's Disease: An Effectiveness Trial.
    Chong R; Wakade C; Seamon M; Giri B; Morgan J; Purohit S
    Front Aging Neurosci; 2021; 13():667032. PubMed ID: 34220485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of GPR109A in Parkinson's disease.
    Wakade C; Chong R; Bradley E; Thomas B; Morgan J
    PLoS One; 2014; 9(10):e109818. PubMed ID: 25329911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-Dose Niacin Supplementation Improves Motor Function in US Veterans with Parkinson's Disease: A Single-Center, Randomized, Placebo-Controlled Trial.
    Wakade C; Chong R; Seamon M; Purohit S; Giri B; Morgan JC
    Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose niacin supplementation modulates GPR109A, niacin index and ameliorates Parkinson's disease symptoms without side effects.
    Wakade C; Chong R; Bradley E; Morgan JC
    Clin Case Rep; 2015 Jul; 3(7):635-7. PubMed ID: 26273459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does levodopa slow or hasten the rate of progression of Parkinson's disease?
    Fahn S;
    J Neurol; 2005 Oct; 252 Suppl 4():IV37-IV42. PubMed ID: 16222436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levodopa/carbidopa intestinal gel can improve both motor and non-motor experiences of daily living in Parkinson's disease: An open-label study.
    Juhász A; Aschermann Z; Ács P; Janszky J; Kovács M; Makkos A; Harmat M; Tényi D; Karádi K; Komoly S; Takáts A; Tóth A; Nagy H; Klivényi P; Dibó G; Dézsi L; Zádori D; Annus Á; Vécsei L; Varannai L; Kovács N
    Parkinsonism Relat Disord; 2017 Apr; 37():79-86. PubMed ID: 28185758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical phenotype of drug-naïve Parkinson's disease based on nonmotor symptoms.
    Lee HM; Lee SS; Kim M; Kang SH; Seo WK; Kim JH; Koh SB
    Arch Gerontol Geriatr; 2015; 61(3):517-22. PubMed ID: 26183203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of depression and anxiety via patient-assessed tremor severity, not physician-reported motor symptom severity, in patients with Parkinson's disease or essential tremor who have undergone deep brain stimulation.
    Achey RL; Yamamoto E; Sexton D; Hammer C; Lee BS; Butler RS; Thompson NR; Nagel SJ; Machado AG; Lobel DA
    J Neurosurg; 2018 Dec; 129(6):1562-1571. PubMed ID: 29473781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Syndrome of rapid eye movement sleep behavior disorder and nocturia in Parkinson's disease].
    Nodel MR; Ukraintseva YV; Yakhno NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):15-20. PubMed ID: 29053115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on the Clinical Features of Parkinson's Disease With Probable Rapid Eye Movement Sleep Behavior Disorder.
    Long K; Wan C; Xiang Y; Liu J; Xu Q; Sun Q; Wang Z; Tian Y; Fang L; Yang Y; Yan X; Tang B; Guo J
    Front Neurol; 2020; 11():979. PubMed ID: 33041969
    [No Abstract]   [Full Text] [Related]  

  • 11. Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort.
    Regnault A; Boroojerdi B; Meunier J; Bani M; Morel T; Cano S
    J Neurol; 2019 Aug; 266(8):1927-1936. PubMed ID: 31073716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of medication and STN-DBS on postural control in subjects with Parkinson's disease.
    Nantel J; McDonald JC; Bronte-Stewart H
    Parkinsonism Relat Disord; 2012 Mar; 18(3):285-9. PubMed ID: 22130147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease.
    Santos-García D; de la Fuente-Fernández R
    J Neurol Sci; 2013 Sep; 332(1-2):136-40. PubMed ID: 23890935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Observational Study of the Effect of Levodopa-Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson's Disease Patients.
    Krüger R; Lingor P; Doskas T; Henselmans JML; Danielsen EH; de Fabregues O; Stefani A; Sensken SC; Parra JC; Onuk K; Yegin A; Antonini A
    Adv Ther; 2017 Jul; 34(7):1741-1752. PubMed ID: 28631218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effectiveness of levodopa-carbidopa intestinal gel on motor and non-motor symptoms in advanced Parkinson's disease: results of the Italian GLORIA patient population.
    Antonini A; Marano P; Gusmaroli G; Modugno N; Pacchetti C; Sensi M; Melzi G; Bergmann L; Zibetti M; Lopiano L
    Neurol Sci; 2020 Oct; 41(10):2929-2937. PubMed ID: 32342325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of bilateral stimulation of the subthalamic nucleus in Parkinson's disease with and without REM sleep behaviour disorder.
    Bargiotas P; Debove I; Bargiotas I; Lachenmayer ML; Ntafouli M; Vayatis N; Schüpbach MW; Krack P; Bassetti CL
    J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1310-1316. PubMed ID: 31422368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chronic bilateral subthalamic nucleus (STN) stimulation on postural control in Parkinson's disease.
    Maurer C; Mergner T; Xie J; Faist M; Pollak P; Lücking CH
    Brain; 2003 May; 126(Pt 5):1146-63. PubMed ID: 12690054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged-release melatonin in Parkinson's disease patients with a poor sleep quality: A randomized trial.
    Ahn JH; Kim M; Park S; Jang W; Park J; Oh E; Cho JW; Kim JS; Youn J
    Parkinsonism Relat Disord; 2020 Jun; 75():50-54. PubMed ID: 32480307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postural sway in patients with early Parkinson's disease performing cognitive tasks while standing.
    Chen T; Fan Y; Zhuang X; Feng D; Chen Y; Chan P; Du Y
    Neurol Res; 2018 Jun; 40(6):491-498. PubMed ID: 29869975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1.
    Wills AM; Pérez A; Wang J; Su X; Morgan J; Rajan SS; Leehey MA; Pontone GM; Chou KL; Umeh C; Mari Z; Boyd J;
    JAMA Neurol; 2016 Mar; 73(3):321-8. PubMed ID: 26751506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.